R. Sankaraneni and D. Lachhwani, Antiepilepticdrugs-A review, Pediatr Ann 1 févr, vol.44, issue.2, pp.36-42, 2015.

, Collège des enseignants en neurologie, 2018.

E. P. Borrelli, E. Y. Lee, A. M. Descoteaux, S. J. Kogut, and A. R. Caffrey, Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System, Epilepsia, vol.59, issue.12, pp.2318-2342, 2018.

B. Berghuis, J. Van-der-palen, G. J. De-haan, D. Lindhout, B. Koeleman et al.,

, Carbamazepine-and oxcarbazepine-induced hyponatremia in people with epilepsy, Epilepsia, vol.58, issue.7, pp.1227-1260, 2017.

R. Mohan, K. Rastogi, R. Bhushan, and S. Verma, Phenytoin-induced gingival enlargement: a dental awakening for patients with epilepsy, BMJ Case Rep, p.2013008679, 2013.

J. Weston, R. Bromley, C. F. Jackson, N. Adab, J. Clayton-smith et al.,

, Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child

, Cochrane Database Syst Rev, vol.11, p.10224, 2016.

D. Bentué-ferrer, M. C. Verdier, and O. Tribut, Suivi thérapeutique pharmacologique de la primidone et du phénobarbital, Thérapie, vol.67, issue.4, pp.381-90, 2012.

G. Zaccara and E. Perucca, Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs, Epileptic Disord, issue.4, pp.409-440, 2014.

P. N. Patsalos, D. J. Berry, B. Bourgeois, J. C. Cloyd, T. A. Glauser et al.,

, Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies, Epilepsia, vol.49, issue.7, pp.1239-76, 2008.

D. M. Ijff and A. P. Aldenkamp, Cognitive side-effects of antiepileptic drugs in children, Handbook of clinical neurology, 2013.

M. J. Brodie, F. Besag, A. B. Ettinger, M. Mula, G. Gobbi et al., Epilepsy, antiepileptic drugs, and aggression: an evidence-based review, Pharmacol Rev, vol.12, issue.3, pp.563-602, 2016.

S. A. Hamed, The auditory and vestibular toxicities induced by antiepileptic drugs, Expert Opin Drug Saf, vol.16, issue.11, pp.1281-94, 2017.

A. Tateno, K. Sawada, I. Takahashi, and Y. Hujiwara, Carbamazepine-induced transient auditory pitch-perception deficit, Pediatr Neurol, vol.35, issue.2, pp.131-135, 2006.

M. J. Maguire, Music and epilepsy: a critical review: music and epilepsy, Epilepsia, vol.53, issue.6, pp.947-61, 2012.

S. Gur-ozmen, N. Nirmalananthan, and T. J. Von-oertzen, Change of pitch due to carbamazepine and oxcarbazepine independently, Seizure, vol.22, issue.2, pp.162-165, 2013.

M. Kawai and K. Kanemoto, A case of auditory disturbance caused by lacosamide, Epilepsy Behav Case Rep, vol.11, pp.70-72, 2019.

P. N. Patsalos, E. P. Spencer, and D. J. Berry, Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update, Ther Drug Monit, vol.40, issue.5, pp.526-574, 2018.

T. Vial, French pharmacovigilance: missions, organization and perspectives, Therapies, vol.71, issue.2, pp.143-50, 2016.